Market Size in 2023 | Market Forecast in 2032 | CAGR (in %) | Base Year |
---|---|---|---|
USD 43.94 Billion | USD 72.37 Billion | 5.70% | 2023 |
The global neuroscience market was valued at around USD 43.94 billion in the year 2023 and it is expected to reach approximately USD 72.37 billion by 2032. The global neuroscience market is expected to exhibit a CAGR of more than 5.70% between 2024 and 2032.
Neuroscience is a subdivision of biology that comprises the study of the development and function of the nervous system and diseases related to it. Neuroscience is a point where the biology meets psychology of the human brain. Neurologists are engaged in a much broad scope of fields than earlier. Their study involves evolutionary, molecular, medical, and functional aspects of the nervous system. The neuroscience market is increasing as the percentage of CNS diseases is increasing globally.
The rise in the occurrences of neurological disorders globally has triggered the growth of the neuroscience market. There has been a rapid increase in the cases of neurological disorders such as cerebral stroke, Alzheimer's disease, epilepsy, and Parkinsonism which has increased the demand for developments in the field of neuroscience. The demand for CNS-related diagnostic procedures has increased which has positively affected the growth of the market. Other factors that are expected to drive the market growth positively are favorable reimbursement policies and the growing government spending on healthcare infrastructure.
The high cost of neurological devices such as magnetic resonance imaging systems will majorly limit the growth of the neuroscience market during the forecast period.
Report Attributes | Report Details |
---|---|
Report Name | Neuroscience Market Research Report |
Market Size in 2023 | USD 43.94 Billion |
Market Forecast in 2032 | USD 72.37 Billion |
Growth Rate | CAGR of 5.70% |
Number of Pages | 214 |
Key Companies Covered | Alpha Omega, Axion Biosystems, Blackrock Microsystems LLC, Femtonics Ltd., Intan Technologies, LaVision Biotec GmbH, Mediso Medical Imaging Systems, Neuralynx Inc., NeuroNexus Technologies, Neurotar Ltd., Newport Corporation, Plexon Inc., Scientifica Ltd., Sutter Instrument Corporation, Thomas Recording GmbH, Trifoil Imaging Inc., and among others. |
Segments Covered | By Component, By End-User, And By Region |
Regions Covered | North America, Europe, Asia Pacific (APAC), Latin America, Middle East, and Africa (MEA) |
Base Year | 2023 |
Historical Year | 2018 to 2022 |
Forecast Year | 2024 - 2032 |
Customization Scope | Avail customized purchase options to meet your exact research needs. Request For Customization |
By component, the instrument segment accounted for the largest market share in 2023. In the instruments segment, the components such as MRI imaging systems, neuro–microscopy, and others accounted for the largest market share. The high cost of these instruments has contributed to the increased revenue contribution of this segment in the neuroscience market. Owing to the increased use of instruments for the diagnosis and treatment of neurological disorders has positively affected the growth of the instruments segment.
However, the software segment is expected to grow with the highest CAGR of more than 35% during the forecast period. The rising trade of neuroscience devices with integrated software for imaging and diagnostics purposes is driving the demand for software in the neuroscience market.
By end-user, hospitals dominated the end-user segment in 2016 by holding a major market share of above 35%. The increasing preference of patients towards hospitals for better diagnosis of their neurological disorders is one of the major factors driving the hospital segment. The quality treatment facilities offered by the hospitals and the availability of advanced equipment have positively increased the growth of the segment
However, it is anticipated that the diagnostics laboratories segment will register the highest CAGR during the forecast period. Growing neurological disorders and the development of technologies are the major factors contributing to the growth of the segment.
North America contributes the largest share of the global neuroscience market. The region dominated the market by accounting highest market share in 2023 and is also expected to retain its dominance during the forecast period. Increasing demand for neuroimaging devices and the growing research activities in the field of neuroscience contribute to the growth of the market in North America.
The Asia Pacific is anticipated to be the most lucrative region for the neuroscience market, owing to the increasing healthcare infrastructure, rising incidences of CNS disorders among the aging population, and increasing health awareness among the population regarding neurological disorders and treatments will boost the growth of the neuroscience market in the Asia Pacific over the forecast period.
By Component
By End-User
By Region
FrequentlyAsked Questions
Neuroscience is a subdivision of biology that comprises the study of the development and function of the nervous system and diseases related to it. Neuroscience is a point where the biology meets psychology of the human brain.
According to study, the global Neuroscience market size was worth around USD 43.94 billion in 2023 and is predicted to grow to around USD 72.37 billion by 2032.
The CAGR value of Neuroscience market is expected to be around 5.70% during 2024-2032.
North America has been leading the global Neuroscience market and is anticipated to continue on the dominant position in the years to come.
The global Neuroscience market is led by players like Alpha Omega, Axion Biosystems, Blackrock Microsystems LLC, Femtonics Ltd., Intan Technologies, LaVision Biotec GmbH, Mediso Medical Imaging Systems, Neuralynx Inc., NeuroNexus Technologies, Neurotar Ltd., Newport Corporation, Plexon Inc., Scientifica Ltd., Sutter Instrument Corporation, Thomas Recording GmbH, Trifoil Imaging Inc., and among others.
RelatedNews
HappyClients
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed